ASLN
NASDAQASLAN Pharmaceuticals Limited
Latest news
25 items- SECSEC Form 25-NSE filed by ASLAN Pharmaceuticals Limited25-NSE - ASLAN Pharmaceuticals Ltd (0001722926) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by ASLAN Pharmaceuticals LimitedSCHEDULE 13G/A - ASLAN Pharmaceuticals Ltd (0001722926) (Subject)
- NEWSTop 3 Health Care Stocks Which Could Rescue Your Portfolio In JulyThe most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. ` The RSI is a momentum indicator, which compares a stock’s strength on days when prices go up to its strength on days when prices go down. When compared to a stock’s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the RSI is below 30, according to Benzinga Pro. Here's the latest list of major oversold players in this sector, having an RSI near or below 30. Aslan Pharmaceuticals Ltd (NASDAQ:ASLN) On July 17, ASLAN Pharmaceuticals announced that its Singapore-incorporated, sole o
- NEWSDow Jumps 200 Points; Synchrony Financial Posts Upbeat EarningsU.S. stocks traded mixed toward the end of trading, with the S&P 500 falling over 1% on Wednesday. The Dow traded up 0.53% to 41,173.41 while the NASDAQ fell 2.51% to 18,044.33. The S&P 500 also fell, dropping, 1.24% to 5,597.06. Check This Out: Amazon To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Wednesday Leading and Lagging SectorsConsumer staples shares jumped by 1.4% on Wednesday. In trading on Wednesday, information technology shares fell by 3.6%. Top Headline Synchrony Financial (NYSE:SYF) reported better-than-expected second-quarter results on Wednesday. The company posted quarterly net interest income of $4.405 billion, beating the consensus of $4.28
- NEWSWhy ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionShares of ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) fell sharply during Wednesday's session after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for voluntary liquidation. ASLAN Pharmaceuticals shares dipped 38.7% to $0.68 on Wednesday. Here are some other stocks moving in today’s mid-day session. Gainers Aptevo Therapeutics Inc. (NASDAQ:APVO) shares climbed 84% to $0.6073 after surging around 10% on Tuesday. Aptevo Therapeutics recently announced closing of $2.75 million offering. Shimmick Corporation (NASDAQ:SHIM) shares climbed 49% to $3.0173 after the company received a $27.6 million subcontract for the Sunol Valley Water Trea
- NEWSWhy ASLAN Pharmaceuticals (ASLN) Shares Are Down 40%ASLAN Pharmaceuticals Ltd (NASDAQ:ASLN) shares are trading lower by 38.7% to $0.68 during Wednesday’s session after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for voluntary liquidation. The company says this decision was made following a thorough review of ASLAN SG’s financial situation and strategic options. As a result, all employees of ASLAN SG and its subsidiary in the USA have been terminated. The directors of ASLAN SG resolved that the subsidiary could not continue its business due to its liabilities. Luke Anthony Furler and Tan Kim Han of Quantuma (Singapore) Pte Limited were appointed as provisional liquidators to manage the windi
- NEWSCrude Oil Rises 2%; Five Below Shares PlungeU.S. stocks traded mixed midway through trading, with the Dow Jones index gaining around 200 points on Wednesday. The Dow traded up 0.50% to 41,160.40 while the NASDAQ fell 2.46% to 18,053.81. The S&P 500 also fell, dropping, 1.15% to 5,601.75. Check This Out: Amazon To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Wednesday Leading and Lagging SectorsReal estate shares jumped by 1% on Wednesday. In trading on Wednesday, information technology shares fell by 3.2%. Top Headline U.S. crude oil inventories declined by 4.87 million barrels in the week ended July 12, falling for the third consecutive week, the EIA said. Equities Trading UP
- NEWSNasdaq Dips 300 Points; Johnson & Johnson Earnings Top EstimatesU.S. stocks traded mostly lower this morning, with the Nasdaq Composite falling around 300 points on Wednesday. Following the market opening Wednesday, the Dow traded down 0.10% to 40,914.80 while the NASDAQ fell 1.63% to 18,208.05. The S&P 500 also fell, dropping, 0.98% to 5,611.77 . Check This Out: Amazon To Rally Around 9%? Here Are 10 Top Analyst Forecasts For Wednesday Leading and Lagging SectorsEnergy shares jumped by 0.5% on Wednesday. In trading on Wednesday, information technology shares fell by 2.3%. Top Headline Johnson & Johnson (NYSE:JNJ) reported better-than-expected second-quarter earnings on Wednesday. The company posted a
- NEWSASLAN Pharmaceuticals shares are trading lower after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for voluntary liquidation.
- SECSEC Form 6-K filed by ASLAN Pharmaceuticals Limited6-K - ASLAN Pharmaceuticals Ltd (0001722926) (Filer)
- NEWSASLAN Pharmaceuticals Announced That Its Sole Operating Subsidiary Has Filed For Voluntary Liquidation And All Employees At ASLAN SG And Fellow Subsidiary ASLAN Pharmaceuticals Have Been Terminated Effective Immediately
- PRASLAN Pharmaceuticals Announces it Has Filed for Voluntary Liquidation of Its Sole Operating Subsidiary and is Commencing Steps to Place Itself Into Voluntary LiquidationFollowing a thorough review of all strategic alternatives, ASLAN Pharmaceuticals Pte Ltd, the sole operating subsidiary of ASLAN Pharmaceuticals, has filed for voluntary liquidation Quantuma (Singapore) Pte Limited International has been appointed as the official liquidator and will seek potential strategic alternatives for the Company's development programs, eblasakimab and farudodstat SAN MATEO, Calif. and SINGAPORE, July 17, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals ("ASLAN" or the "Company"), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that its Singapore-incorporated, sole oper
- NEWSCrude Oil Moves Lower; Goldman Sachs Posts Upbeat ResultsU.S. stocks traded higher toward the end of trading, with the Dow Jones index rising more than 150 points on Monday. The Dow traded up 0.44% to 40,178.06 while the NASDAQ rose 0.29% to 18,451.73. The S&P 500 also rose, gaining, 0.25% to 5,629.59. Check This Out: Over $18M Bet On This Tech Stock? Check Out These 4 Stocks Insiders Are Buying Leading and Lagging SectorsEnergy shares jumped by 2% on Monday. In trading on Monday, utilities shares fell by 1.8%. Top Headline Goldman Sachs Group Inc. (NYSE:GS) reported better-than-expected results for its second quarter. Goldman posted revenue of $12.730 billion for the second quarter, beating the consensus of $12.456 billion.
- NEWSWhy SolarEdge Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day SessionShares of SolarEdge Technologies, Inc. (NASDAQ:SEDG) fell sharply during Monday's session after the company announced a workforce reduction. SolarEdge disclosed a decision to lay off 400 employees. The company stated that 200 of these job cuts are in Israel. The action involves reducing headcount and discretionary spending across all departments. SolarEdge Technologies shares dipped 12.2% to $27.77 on Monday. Here are some other stocks moving in today’s mid-day session. Gainers Autonomix Medical, Inc. (NASDAQ:AMIX) shares climbed 148% to $1.4850 after the company entered into an agreement with RF Innovations to license intellectual property for its Apex 6 Radiofrequency Gener
- NEWSNasdaq Surges Over 1%; Lexeo Therapeutics Shares PlummetU.S. stocks traded higher midway through trading, with the Nasdaq Composite rising more than 200 points on Monday. The Dow traded up 0.73% to 40,291.69 while the NASDAQ rose 1.16% to 18,611.47. The S&P 500 also rose, gaining, 0.81% to 5,660.67. Check This Out: Over $18M Bet On This Tech Stock? Check Out These 4 Stocks Insiders Are Buying Leading and Lagging SectorsEnergy shares jumped by 1.6% on Monday. In trading on Monday, utilities shares fell by 2.1%. Top Headline The NY Empire State Manufacturing Index fell to a reading of -6.6 in July, compared to market estimates of -6. Equities Trading UP Scinai Immunotherapeutics Ltd. (NASDAQ:SCNI) sh
- NEWSASLAN Pharmaceuticals shares are trading lower after the company announced the receipt of a Nasdaq delisting determination.
- NEWSDow Jumps Over 200 Points; NY Empire State Manufacturing Index Falls In JulyU.S. stocks traded higher this morning, with the Dow Jones index gaining more than 200 points on Monday. Following the market opening Monday, the Dow traded up 0.62% to 40,249.41 while the NASDAQ rose 0.52% to 18,493.58. The S&P 500 also rose, gaining, 0.44% to 5,639.94. Check This Out: Over $18M Bet On This Tech Stock? Check Out These 4 Stocks Insiders Are Buying Leading and Lagging SectorsInformation technology shares jumped by 1.1% on Monday. In trading on Monday, utilities shares fell by 1.3%. Top Headline The NY Empire State Manufacturing Index fell to a reading of -6.6 in July, compared to market estimates of -6. Equities Trading UP Scina
- NEWSASLAN Pharmaceuticals Announces Receipt of Nasdaq Delisting Determination For Non-Compliance Of Bid Price And Stockholders' Qquity RequirementsASLAN Pharmaceuticals (("ASLAN" or the "Company", NASDAQ:ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that on July 9, 2024, the Company was notified by the staff of the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") that, based upon the Company's non-compliance with the $1.00 bid price and $2.5 million stockholders' equity requirements for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rules 5550(a)(2) and 5550(b)(1), respectively, the Staff had determined to delist the Company's securities from Nasdaq. Upon c
- PRASLAN Pharmaceuticals Announces Receipt of Nasdaq Delisting Determination; Has Determined Not to AppealSAN MATEO, Calif. and SINGAPORE, July 15, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (("ASLAN" or the "Company", NASDAQ:ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that on July 9, 2024, the Company was notified by the staff of the Listing Qualifications Department (the "Staff") of The Nasdaq Stock Market LLC ("Nasdaq") that, based upon the Company's non-compliance with the $1.00 bid price and $2.5 million stockholders' equity requirements for continued listing on The Nasdaq Capital Market, as set forth in Nasdaq Listing Rules 5550(a)(2) and 5550(b)(1), respectively, the Staff
- SECSEC Form 6-K filed by ASLAN Pharmaceuticals Limited6-K - ASLAN Pharmaceuticals Ltd (0001722926) (Filer)
- NEWSTrading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
- NEWSTrading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending
- SECSEC Form EFFECT filed by ASLAN Pharmaceuticals LimitedEFFECT - ASLAN Pharmaceuticals Ltd (0001722926) (Filer)
- NEWS12 Health Care Stocks Moving In Friday's Pre-Market SessionGainers DermTech (NASDAQ:DMTK) stock rose 56.6% to $0.18 during Friday's pre-market session. The market value of their outstanding shares is at $6.4 million. Sarepta Therapeutics (NASDAQ:SRPT) shares rose 39.26% to $171.99. The market value of their outstanding shares is at $16.2 billion. Kintara Therapeutics (NASDAQ:KTRA) shares increased by 17.78% to $0.32. The market value of their outstanding shares is at $17.9 million. Solid Biosciences (NASDAQ:SLDB) stock moved upwards by 17.3% to $7.39. The market value of their outstanding shares is at $283.6 million. ASLAN Pharma (NASDAQ:ASLN) stock rose 14.06% to $0.36. The market value of their outstanding shares is at $8.2 million. Alaunos
- NEWSWhy Vuzix Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving PremarketShares of Vuzix Corporation (NASDAQ:VUZI) rose sharply in today's pre-market trading after the company disclosed a strategic partnership with Avegant to develop optimized waveguide optical modules for use in future AI-enabled smart glasses. Vuzix shares jumped 15% to $1.53 in the pre-market trading session. Here are some other stocks moving in pre-market trading. Gainers SMX (Security Matters) Public Limited Company (NASDAQ:SMX) rose 109.8% to $0.2497 in pre-market trading after jumping 19% on Tuesday. Selina Hospitality PLC (NASDAQ:SLNA) gained 46.9% to $0.1024 in pre-market trading after declining 7% on Tuesday. Tempest Therapeutics, Inc. (NASDAQ:TPST) shares rose 44.5%
ASLN FAQ
7 questionsWhat does ASLAN Pharmaceuticals Limited do?
ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners...Where does ASLN stock trade?
ASLAN Pharmaceuticals Limited (ASLN) is listed on NASDAQ.What sector and industry is ASLN in?
ASLAN Pharmaceuticals Limited operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did ASLAN Pharmaceuticals Limited go public?
ASLAN Pharmaceuticals Limited (ASLN) completed its IPO in 2018.What are analysts saying about ASLN?
ASLAN Pharmaceuticals Limited has had 1 recent analyst action on file. The most recent action was from Jefferies: Buy with a $800.00 price target on 2021-07-09. Recent price targets cluster around $800.00.What companies are similar to ASLN?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare ASLN side-by-side with any of them on Quantisnow.How can I track ASLN on Quantisnow?
Quantisnow aggregates ASLAN Pharmaceuticals Limited's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ASLN to receive live email and push alerts on every new disclosure.